What pharma PSUs and government vaccine makers can and cannot do in the uphill battle against Covid-19

While government-owned pharma companies are ailing from years of neglect, some have rolled up their sleeves and joined India’s uphill battle against Covid, with plans to manufacture drugs that are used for treatment of Covid-19 patients or to produce vaccines that can shield people from the dreaded SARS-CoV-2 virus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yMin0R
via IFTTT